hrp0097s3.1 | Endocrine effects of cancer treatment | ESPE2023
hrp0097p1-235 | Diabetes and Insulin | ESPE2023
Godbole Tushar , Gogate Yashpal
hrp0097p2-238 | Diabetes and Insulin | ESPE2023
hrp0095p1-402 | Adrenals and HPA Axis | ESPE2022
Park Julie , Hawcutt Daniel , Shantsila Alena , Lip Gregory , Blair Joanne
hrp0095p1-406 | Adrenals and HPA Axis | ESPE2022
Baronio Federico , Ferrari Vittorio , Maltoni Giulio , Alqaisi Randa , Cassio Alessandra
hrp0095p1-102 | GH and IGFs | ESPE2022
Cristina Maggio Maria , Genesia Alizzi Clotilde , Corsello Giovanni
hrp0095p1-308 | Growth and Syndromes | ESPE2022
Bendre Ameya , Ottosson Lars , Baroncelli Marta , Dou Zelong , Nilsson Ola
hrp0095p1-590 | Thyroid | ESPE2022
MacGloin Helen , Bhushan Arya Ved , Schoenmakers Nadia , Buchanan Charles
hrp0095p2-24 | Adrenals and HPA Axis | ESPE2022
Okur Iclal , Arasli-Yilmaz Aslihan , Elmaogullari Selin , Karacan-Kucukali Gulin , Keskin Meliksah , Muratoglu-Sahin Nursel , Kurnaz Erdal , Savas-Erdeve Senay , Cetinkaya Semra
hrp0092s1.3 | Novel Advances in Diabetes and Obesity | ESPE2019